| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9312747 | Urology | 2005 | 5 Pages |
Abstract
No consistent hormonal therapy effects with finasteride treatment were observed compared with LHRH agonists. The hormonal effect was observed in the control group. Therefore, although other aspects of the Prostate Cancer Prevention Trial design might account for the greater percentage of Gleason grade tumors in the study arm, morphologic changes due to long-term finasteride treatment were not a likely cause.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mark A. Rubin, Yves Allory, Vincent Molinié, Xavier Leroy, Hugo Faucon, Francis Vacherot, Wei Huang, Adam Kuten, Laurent Salomon, Xavier Rebillard, Olivier Cussenot, Claude Abbou, Alexandre de la Taille,